Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001372514-23-000145

Options or other derivatives

  • Director acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Stengone Carmine N. Director 2023-09-29 Grant or award · Stock Option (right to buy) +8,000 8,000 D: show line 1 in the form
Loading xslF345X05/wk-form4_1696365916.xml…